Interestingly, the increased oxygen supply relieves the tumor tissue from hypoxia, hence modifying the immunosuppressive TME by suppressing the PD-L1 expression and the M2-type TAMs infiltration in the tumor tissue. The gene discussed is CD274; the disease is neoplasm.